Protagonist Therapeutics Inc
XBER:PGF
Protagonist Therapeutics Inc
XBER:PGF
Price:
75
EUR
Market Closed
Market Cap:
€2.9B
Wall Street
Price Targets
PGF Price Targets Summary
Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Wall Street analysts forecast PGF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PGF
is 77.79 EUR
with a low forecast of 49.8 EUR and a high forecast of 93.99 EUR.
Lowest
Price Target
49.8
EUR
34% Downside
Average
Price Target
77.79
EUR
4% Upside
Highest
Price Target
93.99
EUR
25% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PGF's stock price target?
Price Target
77.79
EUR
77.79
EUR
According to Wall Street analysts, the average 1-year price target for
PGF
is 77.79 EUR
with a low forecast of 49.8 EUR and a high forecast of 93.99 EUR.
What is Protagonist Therapeutics Inc's Revenue forecast?
Projected CAGR
90%
90%
The
compound annual growth rate
of Protagonist Therapeutics Inc's revenue for the next 3 years is
90%.
